WS #12812
AstraZeneca Q2 profit beats estimates, driven by cancer drug sales; raises interim dividend.
AstraZeneca Q2 Earnings Beat
AstraZeneca Q2 profit beats estimates, driven by cancer drug sales; raises interim dividend.
AstraZeneca Q2 profit beats estimates, driven by cancer drug sales; raises interim dividend.
AstraZeneca Q2 profit beats estimates, driven by cancer drug sales; raises interim dividend.